These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19588217)

  • 1. Chronic inflammatory demyelinating polyneuropathy accompanied by chronic myelomonocytic leukemia: possible pathogenesis of autoimmunity in myelodysplastic syndrome.
    Isoda A; Sakurai A; Ogawa Y; Miyazawa Y; Saito A; Matsumoto M; Sawamura M
    Int J Hematol; 2009 Sep; 90(2):239-242. PubMed ID: 19588217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune phenomena in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia.
    Saif MW; Hopkins JL; Gore SD
    Leuk Lymphoma; 2002 Nov; 43(11):2083-92. PubMed ID: 12533032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune disease in CMML-the chicken or the egg?
    Ambinder AJ; Miller J; DeZern AE
    Best Pract Res Clin Haematol; 2020 Jun; 33(2):101136. PubMed ID: 32460986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased cardiovascular comorbidities in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia presenting with systemic inflammatory and autoimmune manifestations.
    Kipfer B; Daikeler T; Kuchen S; Hallal M; Andina N; Allam R; Bonadies N
    Semin Hematol; 2018 Oct; 55(4):242-247. PubMed ID: 30502853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloid Clonal Infiltrate Identified With Next-Generation Sequencing in Skin Lesions Associated With Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: A Case Series.
    Martin de Frémont G; Hirsch P; Gimenez de Mestral S; Moguelet P; Ditchi Y; Emile JF; Senet P; Georgin-Lavialle S; Hanslik T; Maurier F; Adedjouma A; Abisror N; Mahevas T; Malard F; Adès L; Fenaux P; Fain O; Chasset F; Mekinian A
    Front Immunol; 2021; 12():715053. PubMed ID: 34671345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic landscape of MDS/CMML associated with systemic inflammatory and autoimmune disease.
    Zhao LP; Boy M; Azoulay C; Clappier E; Sébert M; Amable L; Klibi J; Benlagha K; Espéli M; Balabanian K; Preudhomme C; Marceau-Renaut A; Benajiba L; Itzykson R; Mekinian A; Fain O; Toubert A; Fenaux P; Dulphy N; Adès L
    Leukemia; 2021 Sep; 35(9):2720-2724. PubMed ID: 33623140
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chronic inflammatory demyelinating polyneuropathy followed by systemic lupus erythematosus and Sjögren syndrome: a case report].
    Hatano T; Fukuda M; Shiotsuki H; Miwa H; Urabe T; Mizuno Y
    Rinsho Shinkeigaku; 2006 Mar; 46(3):203-9. PubMed ID: 16642931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of chronic inflammatory demyelinating polyradiculoneuropathy concomitant with acquired von Willebrand syndrome].
    Ueda M; Kawamura N; Tateishi T; Shigeto H; Ohyagi Y; Kira J
    Rinsho Shinkeigaku; 2011 May; 51(5):334-7. PubMed ID: 21706830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of UBA1 mutations in MDS/CMML patients with systemic inflammatory and auto-immune disease.
    Zhao LP; Schell B; Sébert M; Kim R; Lemaire P; Boy M; Mathis S; Larcher L; Chauvel C; Dhouaieb MB; Bisio V; Preudhomme C; Marceau-Renaut A; Itzykson R; Mekinian A; Fain O; Toubert A; Fenaux P; Dulphy N; Clappier E; Adès L
    Leukemia; 2021 Sep; 35(9):2731-2733. PubMed ID: 34344988
    [No Abstract]   [Full Text] [Related]  

  • 10. Overexpression of Arginase 1 is linked to DNMT3A and TET2 mutations in lower-grade myelodysplastic syndromes and chronic myelomonocytic leukemia.
    Cull AH; Mahendru D; Snetsinger B; Good D; Tyryshkin K; Chesney A; Ghorab Z; Reis M; Buckstein R; Wells RA; Rauh MJ
    Leuk Res; 2018 Feb; 65():5-13. PubMed ID: 29227812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of chronic myelomonocytic leukemia complicated with spondyloarthritis.
    Matsumoto T; Saito T; Kohsaka H
    Mod Rheumatol; 2018 Mar; 28(2):373-375. PubMed ID: 26392142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukaemia: a French multicentre retrospective study.
    Mekinian A; Grignano E; Braun T; Decaux O; Liozon E; Costedoat-Chalumeau N; Kahn JE; Hamidou M; Park S; Puéchal X; Toussirot E; Falgarone G; Launay D; Morel N; Trouiller S; Mathian A; Gombert B; Schoindre Y; Lioger B; De Wazieres B; Amoura Z; Buchdaul AL; Georgin-Lavialle S; Dion J; Madaule S; Raffray L; Cathebras P; Piette JC; Rose C; Ziza JM; Lortholary O; Montestruc F; Omouri M; Denis G; Rossignol J; Nimubona S; Adès L; Gardin C; Fenaux P; Fain O
    Rheumatology (Oxford); 2016 Feb; 55(2):291-300. PubMed ID: 26350487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunopathology and treatments of Guillain-Barré syndrome and of chronic inflammatory demyelinating polyneuropathy].
    Radziwill AJ; Kuntzer T; Steck AJ
    Rev Neurol (Paris); 2002 Mar; 158(3):301-10. PubMed ID: 11976589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory demyelinating neuropathies with focal segmental glomerulosclerosis: Two case reports.
    Mao Y; Zhang M; Liu S; Xu Y; Xue J; Hao C; Lai L
    Medicine (Baltimore); 2018 Dec; 97(49):e13304. PubMed ID: 30544390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facial and trigeminal neuropathies as the initial manifestation of chronic inflammatory demyelinating polyradiculopathy.
    Varela H; Rubin DI
    J Clin Neuromuscul Dis; 2009 Jun; 10(4):194-8. PubMed ID: 19494731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trisomy 14 in myelodysplastic syndromes: report of two cases and review of the literature.
    Vasef MA; Murata-Collins JL; Alsabeh R; Medeiros LJ
    Arch Pathol Lab Med; 1998 Jan; 122(1):77-83. PubMed ID: 9448022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic myelomonocytic leukemia with polyneuropathy and IgA-paraprotein.
    Maeda T; Ashie T; Kikuiri K; Ishiyama N; Takakura M; Ise T
    Jpn J Med; 1989; 28(6):709-16. PubMed ID: 2561295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoid pneumonia with chronic myelomonocytic leukemia.
    Itoh Y; Segawa H; Kito K; Hodohara K; Ishigaki H; Sugihara H; Fujiyama Y; Ogasawara K
    Pathol Res Pract; 2009; 205(2):143-7. PubMed ID: 18805647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transformation of chronic myelomonocytic leukemia to acute lymphoblastic leukemia: case report and review of the literature of lymphoblastic transformation of myelodysplastic syndrome.
    Kouides PA; Bennett JM
    Am J Hematol; 1995 Jun; 49(2):157-62. PubMed ID: 7771469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of cell surface antigen phenotype in guiding therapeutic decisions in chronic myelomonocytic leukemia.
    Woodlock TJ; Seshi B; Sham RL; Cyran EM; Bennett JM
    Leuk Res; 1994 Mar; 18(3):173-81. PubMed ID: 7511190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.